199 related articles for article (PubMed ID: 27292130)
1. Lethal ALAS2 mutation in males X-linked sideroblastic anaemia.
Rose C; Callebaut I; Pascal L; Oudin C; Fournier M; Gouya L; Lambilliotte A; Kannengiesser C
Br J Haematol; 2017 Aug; 178(4):648-651. PubMed ID: 27292130
[No Abstract] [Full Text] [Related]
2. Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia.
Qiu Y; Cai H; Cui L; Liu YX; Wang YN; Li J; Cao XX
Ann Hematol; 2020 Feb; 99(2):371-373. PubMed ID: 31848684
[No Abstract] [Full Text] [Related]
3. Mutation Analysis of X-linked Sideroblastic Anemia in a 12-Month-Old Boy by Massively Parallel Sequencing.
Yu HJ; Lee YJ; Shim JW; Kim DS; Shim JY; Park MS; Woo HY; Park H; Jung HL; Kwon MJ
Ann Lab Med; 2018 Jul; 38(4):389-392. PubMed ID: 29611395
[No Abstract] [Full Text] [Related]
4. X-linked Sideroblastic Anemia in a Malay Boy With ALAS2 S568G Mutation.
Susanto TAK; Bhattacharyya R
J Pediatr Hematol Oncol; 2017 Jul; 39(5):408-409. PubMed ID: 28644307
[TBL] [Abstract][Full Text] [Related]
5. A Novel
Lee JS; Gu J; Yoo HJ; Koh Y; Kim HK
Ann Clin Lab Sci; 2017 May; 47(3):319-322. PubMed ID: 28667034
[TBL] [Abstract][Full Text] [Related]
6. A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review.
Fujiwara T; Fukuhara N; Ichikawa S; Kobayashi M; Okitsu Y; Onishi Y; Furuyama K; Harigae H
Ann Hematol; 2017 Nov; 96(11):1955-1957. PubMed ID: 28840292
[No Abstract] [Full Text] [Related]
7. Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation.
Cazzola M; May A; Bergamaschi G; Cerani P; Ferrillo S; Bishop DF
Blood; 2002 Dec; 100(12):4236-8. PubMed ID: 12393718
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation, Ile289Thr, in the ALAS2 gene in a family with pyridoxine responsive sideroblastic anaemia.
Percy MJ; Cuthbert RJ; May A; McMullin MF
J Clin Pathol; 2006 Sep; 59(9):1002. PubMed ID: 16935983
[No Abstract] [Full Text] [Related]
9. [A case report of X-linked sideroblastic anemia with novel ALAS2 gene mutation].
Bao SJ; Zhu HM; Tong Y; Hao D; Ling Y; Yuan W; Zhou Y; Sun ZQ
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):684. PubMed ID: 31495138
[No Abstract] [Full Text] [Related]
10. Novel mutations in the ALAS2 gene from patients with X-linked sideroblastic anemia.
Li J; Chen L; Lin Y; Ru K
Int J Lab Hematol; 2020 Aug; 42(4):e160-e163. PubMed ID: 32297424
[No Abstract] [Full Text] [Related]
11. A novel hemizygous I418S mutation in the ALAS2 gene in a young Korean man with X-linked sideroblastic anemia.
Moon SY; Jun IJ; Kim JE; Lee SJ; Kim HK; Yoon SS
Ann Lab Med; 2014 Mar; 34(2):159-62. PubMed ID: 24624355
[No Abstract] [Full Text] [Related]
12. [Congenital sideroblastic anemia-a new family with identification of K156E mutation of ALAS2 gene and literature review].
Cui R; Xu Z; Qin T; Zhang Y; Xiao Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):142-6. PubMed ID: 24606657
[TBL] [Abstract][Full Text] [Related]
13. A Novel g.55040074delT in ALAS2 Gene Resulting in a Monomeric Protein and Severe Sideroblastic Anemia Phenotype.
Bhatia P; Singh A; Hedge A
J Pediatr Hematol Oncol; 2017 Aug; 39(6):463-465. PubMed ID: 28731922
[TBL] [Abstract][Full Text] [Related]
14. Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity.
Furuyama K; Harigae H; Heller T; Hamel BC; Minder EI; Shimizu T; Kuribara T; Blijlevens N; Shibahara S; Sassa S
Eur J Haematol; 2006 Jan; 76(1):33-41. PubMed ID: 16343269
[TBL] [Abstract][Full Text] [Related]
15. Different haematological picture of congenital sideroblastic anaemia in a hemizygote and a heterozygote.
Aguiar E; Freitas MI; Barbot J
Br J Haematol; 2014 Aug; 166(4):469. PubMed ID: 24862439
[No Abstract] [Full Text] [Related]
16. A double red cells population in a woman with a microcytic anemia.
Garçon L; Kannengiesser C
Blood; 2014 Feb; 123(6):808. PubMed ID: 24660232
[No Abstract] [Full Text] [Related]
17. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns.
Aivado M; Gattermann N; Rong A; Giagounidis AA; Prall WC; Czibere A; Hildebrandt B; Haas R; Bottomley SS
Blood Cells Mol Dis; 2006; 37(1):40-5. PubMed ID: 16735131
[TBL] [Abstract][Full Text] [Related]
18. Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis.
Jardine PE; Cotter PD; Johnson SA; Fitzsimons EJ; Tyfield L; Lunt PW; Bishop DF
J Med Genet; 1994 Mar; 31(3):213-8. PubMed ID: 7912287
[TBL] [Abstract][Full Text] [Related]
19. X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations.
Campagna DR; de Bie CI; Schmitz-Abe K; Sweeney M; Sendamarai AK; Schmidt PJ; Heeney MM; Yntema HG; Kannengiesser C; Grandchamp B; Niemeyer CM; Knoers NV; Swart S; Marron G; van Wijk R; Raymakers RA; May A; Markianos K; Bottomley SS; Swinkels DW; Fleming MD
Am J Hematol; 2014 Mar; 89(3):315-9. PubMed ID: 24166784
[TBL] [Abstract][Full Text] [Related]
20. X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.
Donker AE; Raymakers RA; Nieuwenhuis HK; Coenen MJ; Janssen MC; MacKenzie MA; Brons PP; Swinkels DW
Neth J Med; 2014 May; 72(4):210-7. PubMed ID: 24829177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
